Advertisement
Screener

KIORA PHARMACEUTICALS, INC. (KPRX) Increase (Decrease) in Restricted Cash

2.8 / 5 stars · 68/120 Roast Me

KIORA PHARMACEUTICALS, INC. Increase (Decrease) in Restricted Cash

KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase (Decrease) in Restricted Cash of $0 for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-14.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-11-14

  • KIORA PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-09-30 was $0.00.
  • KIORA PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
  • KIORA PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
  • KIORA PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
  • KIORA PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2016 was $25.00K, a 25.00% increase from fiscal 2015.
  • KIORA PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2015 was $20.00K.
  • KIORA PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2014 was $0.00.
Period endIncrease (Decrease) in Restricted Cash 3 monthIncrease (Decrease) in Restricted Cash 6 monthIncrease (Decrease) in Restricted Cash 9 monthIncrease (Decrease) in Restricted Cash 12 month
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$0.00
derived: sum of 2 quarters · filed 2017-11-14
$0.00
10-Q · filed 2017-11-14
$0.00
derived: sum of 4 quarters · filed 2017-11-14
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$0.00
10-Q · filed 2017-08-04
$0.00
derived: sum of 3 quarters · filed 2017-08-04
$0.00
derived: sum of 4 quarters · filed 2017-11-14
2017-03-31$0.00
10-Q · filed 2017-05-05
$0.00
derived: sum of 2 quarters · filed 2017-05-05
$0.00
derived: sum of 3 quarters · filed 2017-11-14
$15.00K
derived: sum of 4 quarters · filed 2017-11-14
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$0.00
derived: sum of 2 quarters · filed 2017-11-14
$15.00K
derived: sum of 3 quarters · filed 2017-11-14
$25.00K
10-K · filed 2017-02-23
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$15.00K
derived: sum of 2 quarters · filed 2017-11-14
$25.00K
10-Q · filed 2017-11-14
$25.00K
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$15.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$25.00K
10-Q · filed 2017-08-04
$25.00K
derived: sum of 3 quarters · filed 2017-08-04
$25.00K
derived: sum of 4 quarters · filed 2017-08-04
2016-03-31$10.00K
10-Q · filed 2017-05-05
$10.00K
derived: sum of 2 quarters · filed 2017-05-05
$10.00K
derived: sum of 3 quarters · filed 2017-05-05
$10.00K
derived: sum of 4 quarters · filed 2017-05-05
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
$0.00
derived: sum of 2 quarters · filed 2017-02-23
$0.00
derived: sum of 3 quarters · filed 2017-02-23
$20.00K
10-K · filed 2017-02-23
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01
$0.00
derived: sum of 2 quarters · filed 2016-11-01
$20.00K
10-Q · filed 2016-11-01
$20.00K
derived: sum of 4 quarters · filed 2016-11-01
2015-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
$20.00K
10-Q · filed 2016-08-10
$20.00K
derived: sum of 3 quarters · filed 2016-08-10
$20.00K
derived: sum of 4 quarters · filed 2016-08-10
2015-03-31$20.00K
10-Q · filed 2016-05-13
$20.00K
derived: sum of 2 quarters · filed 2016-05-13
$20.00K
derived: sum of 3 quarters · filed 2016-05-13
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$0.00
derived: sum of 2 quarters · filed 2016-03-30
$0.00
10-K · filed 2016-03-30
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
$0.00
10-Q · filed 2015-11-12
2014-06-30$0.00
10-Q · filed 2015-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
BIOVIE INC. (BIVI)United States$0.012B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33